Today, at a medical conference being hosted by the Michael J. Fox Foundation, a biotechnology is presenting the first human data from a Parkinson’s drug that several of the world’s largest drug companies nearly abandoned.
Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox
